CJC-1295 is a growth hormonereleasing hormone (GHRH) analog similar to Sermorelin, but its DAC (drug affinity complex) modification gives it a much longer half-life that lasts for days instead of minutes
[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., Ghatei M.A., Small C., Bloom S.R
Together, they support: More consistent growth hormone activity Improved fat reduction Better muscle preservation Enhanced recovery Stronger metabolic support Many providers recommend combination therapy when patients want broad improvements across body composition, performance, and aging support
Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI (2006) Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy
Low IGF-1 levels are associated with heart failure, reduced brain cell regulation, and impaired neuron function
C E